Article
Mitochondria: A Novel Therapeutic Target in Diabetic Nephropathy
10 May 2017
Abstract excerpt
BACKGROUND: Diabetic nephropathy (DN) is an important diabetic microvascular complication, and it is becoming the leading cause of end-stage renal disease worldwide. Unfortunately, there are no effective therapies to treat established DN. Therefore, new therapeutic targets are urgently required. Accumulating studies indicate that mitochondrial dysfunction is central to the pathogenesis of DN, and therapies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
